Pricing Log in Create free account

Biophytis SA Sponsored ADR (BPTSY) vs Virax Biolabs Group Limited (VRAX)

Biophytis SA Sponsored ADR and Virax Biolabs Group Limited are both Biotechnology companies. Biophytis SA Sponsored ADR and Virax Biolabs Group Limited are of similar size ($2.4M and $2.2M). Across the 6 metrics below, Biophytis SA Sponsored ADR leads on 3 and Virax Biolabs Group Limited on 3.

Valuation

Metric BPTSY VRAX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.86 0.64
EV/Sales n/m n/m 9.21
Earnings yield (126.92%) (367.59%) (33.15%)
Free cash flow yield (2,235.65%) 0.00% (25.50%)

Profitability

Metric BPTSY VRAX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin — — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (56.36%)
Return on assets 0.00% 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BPTSY VRAX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (59.60%) 68.79% 30.26%
Revenue growth, 5-year CAGR — (36.88%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTSY VRAX Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 0.35 9.97 4.72
Net debt to EBITDA (1.24) 1.08 0.96

Dividend

Metric BPTSY VRAX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BPTSY VRAX Biotechnology median
Market cap 2.36m 2.18m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack